Arbutus Biopharma Corporation (GB:0SGC)

Arbutus Biopharma (0SGC) Financial Statements


Arbutus Biopharma Financial Overview

Arbutus Biopharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Arbutus Biopharma is scheduled to report earnings on August 3, 2023, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 5.51M$ 6.25M$ 5.95M$ 14.24M$ 12.58M
Gross Profit$ 6.69M$ 6.25M---
EBIT$ -17.41M$ -22.05M$ -17.14M$ -13.71M$ -10.81M
EBITDA$ -17.46M$ -21.99M$ -16.80M$ -13.33M$ -10.42M
Net Income Common Stockholders$ 32.17M$ -21.42M$ -17.57M$ -14.19M$ -15.77M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 146.73M$ 146.91M$ 134.72M$ 150.20M$ 165.48M
Total Assets$ 191.22M$ 195.42M$ 203.80M$ 215.84M$ 236.88M
Total Debt$ 2.12M$ 2.19M$ 2.31M$ 2.46M$ 2.54M
Net Debt$ -144.61M$ -144.73M$ -132.40M$ -147.73M$ -162.94M
Total Liabilities$ 47.31M$ 195.42M$ 58.28M$ 62.69M$ 71.03M
Stockholders Equity$ 143.91M$ 136.85M$ 145.52M$ 153.14M$ 165.84M
Cash Flow-
Free Cash Flow$ -27.69M$ -19.40M$ -18.78M$ -20.50M$ 20.54M
Operating Cash Flow$ -27.57M$ -19.25M$ -18.69M$ -20.29M$ 20.62M
Investing Cash Flow$ 16.95M$ 14.91M$ -13.74M$ -13.83M$ -60.06M
Financing Cash Flow$ 20.42M$ 11.08M$ 9.13M$ 113.00K$ 11.48M
Currency in USD

Arbutus Biopharma Earnings and Revenue History

Arbutus Biopharma Debt to Assets

Arbutus Biopharma Cash Flow

Arbutus Biopharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis